(Q44105751)

29 November 2017

title

Using primary site as a predictor of survival in mantle cell lymphoma (English)

1 reference

29 November 2017

3

Loretta J Nastoupil

1 reference

29 November 2017

Alexander J Ambinder

1

1 reference

29 November 2017

Pareen J Shenoy

series ordinal

2

1 reference

29 November 2017

Christopher R Flowers

series ordinal

4

1 reference

29 November 2017

language of work or name

English

0 references

publication date

22 January 2013

1 reference

29 November 2017

1 reference

29 November 2017

volume

119

1 reference

29 November 2017

issue

8

1 reference

29 November 2017

page(s)

1570-1577

1 reference

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27898

Incidence trends of mantle cell lymphoma in the United States between 1992 and 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27898

Mantle cell lymphoma: recent insights into pathogenesis, clinical variability, and new diagnostic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27898

A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27898

Validation, revision and extension of the Mantle Cell Lymphoma International Prognostic Index in a population-based setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27898

The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27898

Prognostic relevance of clinical risk factors in mantle cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27898

Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the German Low Grade Lymphoma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27898

Genomic and Gene Expression Profiling Defines Indolent Forms of Mantle Cell Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27898

Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27898

Indolent mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27898

Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27898

InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27898

Mucosal mantle cell (centrocytic) lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27898

The leukemic presentation of mantle-cell lymphoma: disease features and prognostic factors in 58 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27898

Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27898

Outcome of deferred initial therapy in mantle-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27898

Time to treatment does not influence overall survival in newly diagnosed mantle-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27898

The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27898

WHO-EORTC classification for cutaneous lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27898

Primary cutaneous large B-cell lymphomas: clinicopathologic features, classification, and prognostic factors in a large series of patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27898

Epidemiology and etiology of mantle cell lymphoma and other non-Hodgkin lymphoma subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27898

Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27898

Genetic variation in chromosomal translocation breakpoint and immune function genes and risk of non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27898

Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27898

Incidence and outcomes of the peripheral T-cell lymphoma subtypes in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27898

Incidence patterns and outcomes for hodgkin lymphoma patients in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27898

Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27898

Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27898

Changes in cancer registry coding for lymphoma subtypes: reliability over time and relevance for surveillance and study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27898

Survival trends in mantle cell lymphoma in the United States over 16 years 1992-2007

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27898

7 January 2021

Outcome prediction of advanced mantle cell lymphoma by international prognostic index versus different mantle cell lymphoma indexes: one institution study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27898

7 January 2021

A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27898

7 January 2021

Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27898

7 January 2021

Gastrointestinal involvement in mantle cell lymphoma: a prospective clinic, endoscopic, and pathologic study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27898

7 January 2021

Classifying primary gut lymphomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27898

7 January 2021

Multiple lymphomatous polyposis of the gastrointestinal tract. An extensive histopathologic and immunohistochemical study of 12 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27898

7 January 2021

New prognostic relevant factors in primary cutaneous diffuse large B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27898

7 January 2021

Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27898

7 January 2021

Autoimmune and Chronic Inflammatory Disorders and Risk of Non-Hodgkin Lymphoma by Subtype

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27898

7 January 2021

Identifiers

DOI

10.1002/CNCR.27898

1 reference

29 November 2017

1 reference